• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

ABO and Lewis Blood Groups Linked to Lower COVID-19 Susceptibility

October 26, 2022

Blood group O has been associated with decreased risk of SARS-CoV-2 infection in several small studies.  In order to confirm these observations and determine if other blood groups are associated with SARS-CoV-2 infection, researchers in Denmark utilized data from the nationwide SCANDAT database.  SCANDAT is a complete database of all Danish blood donors, including data on SARS-CoV-2 PCR and antigen tests, sex, age, and more than a dozen blood groups.  Using data from SCANDAT from February 2020 to August 2021, 36,068 of 650,156 Danish blood donors tested positive for SARS-CoV-2.  In a multivariable analysis that included adjustment for age and sex, two antigens—blood type O and Lewis Lea—were associated with a lower odds of SARS-CoV-2 infection.  The odds of infection for blood types B, A, and AB compared to O were 1.10 (95% C.I., 1.06 to 1.14), 1.17 (95% C.I., 1.14 to 1.20), and 1.20 (95% C.I. 1.14 to 1.26), respectively.  The odds of infection for the non-secretor Lewis phenotype Lea was 0.88 (95% C.I., 0.78 to 0.99) compared to the secretor phenotype where the ABO blood group antigens are present in other body fluids including mucus.  No associations were found between blood groups and hospitalization or long-COVID.  Further research is needed to understand the mechanisms of blood groups and COVID-19 susceptibility.

Reference:

Moslemi C, Sækmose, Larsen R, Brodersen T, et al.  A large cohort study of the effects of the Lewis, ABO, 13 other blood groups and secretor status on COVID-19 susceptibility, severity, and long COVID-19.   Transfusion 2022

Filed Under

  • News
  • Serology/Genotyping

Recommended

  • Platelet Markers Associated with Bleeding in Immune Thrombocytopenia Patients

  • Zika Virus RNA Can Shed for More Than 6 Months in Semen from Some Infected Men

  • Cryopreserved Platelets Are Safe and Prevent Bleeding

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley